by EMOL Admin | May 29, 2024 | Healthcare Quality
EMOL Health, a data aggregation company for community oncology practices, Ray D. Page, DO, and AstraZeneca announce that their abstract has been accepted for presentation at the 2024 IASLC World Conference on Lung Cancer to be held in San Diego, September 7-10. The...
by EMOL Admin | Nov 28, 2023 | EMOL Partners
Continuing in their long-term collaboration in data management in multiple myeloma, EMOL is proud to announce the contribution of its Founder & CEO, Brian Decker in the recently published Study Assessing the All4Cure Health Technology Intervention on Patient...
by EMOL Admin | Nov 1, 2023 | Healthcare Quality
Published in Targeted Oncology (ePub 2023 Nov 1), Trilaciclib Enhances Survival in ES-SCLC,According to Real-World Data, discusses the implications of the findings from data manuallycurated by EMOL Health, in collaboration with Ajeet Gajra, MD, and G1 Therapeutics....
by EMOL Admin | Oct 28, 2023 | Healthcare Quality
EMOL Health, a data aggregation company for community oncology practices, Ajeet Gajra, MD, and G1 Therapeutics presented a poster at the 2023 ASCO Quality Care Symposium in Boston. Myelosuppression and healthcare utilization among patients with chemotherapy-treated...
by EMOL Admin | Oct 19, 2023 | EMOL Partners
EMOL Health would like to congratulate its partner, The National Cancer Treatment Alliance (NCTA), as they launch a nationwide, clinically integrated network (CIN) of leading community oncology practices and pharmacies. Joining the CIN are 43 practices across 24...
